within Pharmacolibrary.Drugs.ATC.J;

model J01RA04
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.25,
    Cl             = 0.03333333333333333,
    adminDuration  = 600,
    adminMass      = 1.5,
    adminCount     = 1,
    Vd             = 0.06,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.005,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Spiramycin and metronidazole is a fixed-dose combination antibacterial medication used primarily for the treatment of mixed infections, especially dental and orofacial infections. Spiramycin is a macrolide antibiotic, while metronidazole is an antibiotic and antiprotozoal agent. The combination is approved in some countries but not all, and is not approved in the United States.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic parameters for the combination product (spiramycin and metronidazole) are available. The following parameters are estimated based on separate pharmacokinetic data for the individual components in healthy adults after oral administration.</p><h4>References</h4><ol><li><p>Sagan, C, Salvador, A, Dubreuil, D, Poulet, PP, Duffaut, D, &amp; Brumpt, I (2005). Simultaneous determination of metronidazole and spiramycin I in human plasma, saliva and gingival crevicular fluid by LC-MS/MS. <i>Journal of pharmaceutical and biomedical analysis</i> 38(2) 298–306. DOI:<a href=&quot;https://doi.org/10.1016/j.jpba.2004.12.033&quot;>10.1016/j.jpba.2004.12.033</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15925222/&quot;>https://pubmed.ncbi.nlm.nih.gov/15925222</a></p></li><li><p>Poulet, PP, Duffaut, D, Barthet, P, &amp; Brumpt, I (2005). Concentrations and in vivo antibacterial activity of spiramycin and metronidazole in patients with periodontitis treated with high-dose metronidazole and the spiramycin/metronidazole combination. <i>The Journal of antimicrobial chemotherapy</i> 55(3) 347–351. DOI:<a href=&quot;https://doi.org/10.1093/jac/dki013&quot;>10.1093/jac/dki013</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15695539/&quot;>https://pubmed.ncbi.nlm.nih.gov/15695539</a></p></li><li><p>Rotzetter, PA, Le Liboux, A, Pichard, E, &amp; Cimasoni, G (1994). Kinetics of spiramycin/metronidazole (Rodogyl) in human gingival crevicular fluid, saliva and blood. <i>Journal of clinical periodontology</i> 21(9) 595–600. DOI:<a href=&quot;https://doi.org/10.1111/j.1600-051x.1994.tb00749.x&quot;>10.1111/j.1600-051x.1994.tb00749.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7806675/&quot;>https://pubmed.ncbi.nlm.nih.gov/7806675</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end J01RA04;
